Navigation Links
GlaxoSmithKline Offers New Purchasing Options to Help Employers Overcome Barriers to Pandemic Stockpiling of Relenza(R)
Date:9/3/2008

PHILADELPHIA, Sept. 3 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) announced today the launch of the RELENZA(R) (zanamivir) Inhalation Powder Pandemic Readiness for Employers Program (P.R.E.P.) that enables businesses two options when stockpiling RELENZA in preparation for an influenza pandemic. Under the new plan, businesses will have the option to purchase Relenza now at a discounted rate with free storage or to reserve quantities of Relenza for future purchase at a capped rate with a nominal annual fee.

"We are committed to helping employers and other business leaders prepare for an influenza pandemic and its impact on the health of their employees and the operational integrity of their organizations," said Chris Viehbacher, President, North American Pharmaceuticals, GlaxoSmithKline. "By offering employers these options, we aim to reduce the storage and cost barriers associated with implementing an antiviral stockpiling program."

The U.S. Department of Health and Human Services (HHS) encourages employers to take the lead in protecting their workforce and to stockpile the antivirals they will need to protect their employees. HHS acknowledges the importance of diversifying stockpiles and recommends the stockpiling of existing antiviral drugs as part of a comprehensive pandemic plan.

"A diversified stockpile of antivirals is important as we are coming to understand that our concerns for the past few years about resistance of pandemic influenza viruses to antivirals were justified," said Anne Moscona, M.D., Professor of Pediatrics and of Microbiology and Immunology and Vice Chair for Research of Pediatrics, New York-Presbyterian Hospital/Weill Cornell Medical Center. "The recent article in Nature, further explaining the mechanism for this emerging resistance, reinforced the importance of diversifying your antiviral stockpiles in order to help protect the broadest number of employees."

P.R.E.P. includes two purchasing option
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. GlaxoSmithKline To Post Quarterly US Grants Report
2. GlaxoSmithKline - Q2 Results and Strategy Update - Interview with CEO
3. Exelixis and GlaxoSmithKline Agree to Successfully Conclude Six-Year Discovery and Development Collaboration
4. CDC Immunization Advisory Committee Recommends Two New Pediatric Vaccines from GlaxoSmithKline
5. FDA Approves GlaxoSmithKlines AVODART(R) in Combination with Tamsulosin for the Treatment of Symptomatic Enlarged Prostate
6. GlaxoSmithKline and Mpex Pharmaceuticals Form Alliance to Develop Novel Efflux Pump Inhibitors for Use Against Serious Gram-Negative Infections
7. GlaxoSmithKline Signs Licensing Agreement With Compendia Bioscience
8. GlaxoSmithKline Named A Top Employer for Promoting Healthy Lifestyles
9. GlaxoSmithKline Commences Tender Offer to Acquire Sirtris Pharmaceuticals
10. GlaxoSmithKline to Acquire Sirtris Pharmaceuticals, a World Leader in Sirtuin Research and Development
11. Pharmacopeia to Receive $5 Million Payment from GlaxoSmithKline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... CA (PRWEB) January 15, 2014 ... research solutions, today announced that Lupin Limited, one of ... Freeslate’s CM Protégé PharmD System for high ... Mumbai, India, is focused on a wide range of ...
(Date:1/14/2014)... Carahsoft and CDS Federal Services have scheduled a ... EST (11am PST), “Natural Language Processing: Converting Raw Data ... can turn raw, heterogeneous data into actionable knowledge to ... webinar will last approximately one hour. , Synopsis: Big ...
(Date:1/14/2014)... EquitiesIQ, a leading informational research provider, has ... an emerging biomedical company acquiring, developing, manufacturing, and marketing ... Free report download: http://equitiesiq.com/reports/alliqua/ , In late ... and Board, which launched the company’s new strategy to ...
(Date:1/14/2014)... Toronto, Canada (PRWEB) January 14, 2014 ... and its motives and methods in product development and ... of the industry. This mistrust, fueled by concerns about ... further fed by reports of spectacular fines to the ...
Breaking Biology Technology:Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3
... Labs, Inc. (OTC Bulletin Board: GOVX ), a ... today announced the results of its Annual Shareholders Meeting, held ... re-elected seven nominees for directors of the company to serve ... successors are duly elected or appointed and qualified. They are: ...
... Inc., (OTC Bulletin Board: BHRT ) announces ... stem cell therapy on the first two congestive heart ... Tijuana through its Center of Excellence, Regenerative Medicine Institute ... agreement to establish a Center of Excellence for the ...
... 26 Verenium Corporation (Nasdaq: VRNM ... of high-performance industrial enzyme solutions, today announced the ... Vice President of Manufacturing. Bracken will report to ... Verenium,s Enzymes Business. "Kevin brings over ...
Cached Biology Technology:GeoVax Labs Inc. Announces Results of 2010 Annual Stockholders Meeting 2GeoVax Labs Inc. Announces Results of 2010 Annual Stockholders Meeting 3GeoVax Labs Inc. Announces Results of 2010 Annual Stockholders Meeting 4Bioheart Reports Significant Improvements in Heart Failure Patients from Center of Excellence Program 2Bioheart Reports Significant Improvements in Heart Failure Patients from Center of Excellence Program 3Bioheart Reports Significant Improvements in Heart Failure Patients from Center of Excellence Program 4Verenium Appoints Kevin Bracken Vice President of Manufacturing 2Verenium Appoints Kevin Bracken Vice President of Manufacturing 3
(Date:4/24/2014)... they often inject harmful proteins into the host ... However, in some plants, bacteria attack once they,ve ... Now, researchers at the University of Missouri have ... bacteriaknown mostly for attacking tomatoesto invade its host. ... that work with food-producing plants to enhance resistance ...
(Date:4/24/2014)... Rochelle, NY, April 24, 2014GEN Publishing recently introduced ... digital publication focusing on the application of OMICs ... as next-gen sequencing, are beginning to transform medical ... research over the past decade-and-a-half. , "GEN,s editors ... of pharmacogenomics, genomics, metabolomics, transcriptomics, etc. etc. for ...
(Date:4/24/2014)... New Rochelle, NY, April 24, 2014D-ribose is a ... nutritional supplement, and as a starting compound for ... of Escherichia coli to increase the ... step toward achieving more efficient industrial-scale production of ... in Industrial Biotechnology , a peer-reviewed journal ...
Breaking Biology News(10 mins):Plants send out signals attracting harmful bacteria, MU study finds 2
... LUMPUR, Malaysia, Oct. 17, 2012 Rising crime ... governments to increase monitoring and introduce reliable border ... aimed at criminal identification and automated immigration at ... drive biometrics adoption in the government vertical across ...
... 2012  Aware, Inc. (NASDAQ: AWRE ), a ... products, today reported financial results for its third quarter ... DSL service assurance hardware business have been reported as ... shutdown of that business during the third quarter. Accordingly, ...
... Adm. Matthew Klunder, the chief of naval research, told a ... and technology (S&T) conference this week that he intends to ... together on a quarterly basis, starting in 2013, to accelerate ... every two years, which is phenomenal and very valuableand probably ...
Cached Biology News:Increased Focus on Security Bolsters Growth of Biometrics Market in Asia-Pacific, Finds Frost & Sullivan 2Increased Focus on Security Bolsters Growth of Biometrics Market in Asia-Pacific, Finds Frost & Sullivan 3Increased Focus on Security Bolsters Growth of Biometrics Market in Asia-Pacific, Finds Frost & Sullivan 4Aware, Inc. Reports Third Quarter 2012 Financial Results 2Aware, Inc. Reports Third Quarter 2012 Financial Results 3Aware, Inc. Reports Third Quarter 2012 Financial Results 4Aware, Inc. Reports Third Quarter 2012 Financial Results 5Aware, Inc. Reports Third Quarter 2012 Financial Results 6In an uncertain world, Navy needs science and technology collaboration, chief says 2
... Mouse C2C12 cells were cultured in DMEM and ... In order to keep the antigens in their ... The cells are arrayed on a 12-well (5 ... specifically treated to enhance cellular attachment and to ...
... Sample Buffer is a convenient, ... experimental samples and Perfect RNA ... needs no dilution and is ... gels. Simply mix equal volumes ...
... cells were cultured in DMEM and harvested at ... to keep the antigens in their native forms, ... are arrayed on a 12-well (5 mm) adhesive ... to enhance cellular attachment and to minimize background ...
... CopyControl™ vector can be induced prior to ... provide the stability of single-copy BACs with ... other cloning vectors. The kits provide the ... insert size screening system) necessary to create ...
Biology Products: